Results 1 to 10 of about 90,842 (160)

Advanced Oropharyngeal Cancer Can Be Easily Missed During Esophagogastroduodenoscopy [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2017
The case of an elderly man with an advanced oropharyngeal cancer that was missed during esophagogastroduodenoscopy is described. He was referred for endoscopic resection of superficial esophageal squamous cell neoplasms.
Kenta Hamada   +3 more
doaj   +3 more sources

Head and neck squamous cell carcinoma [PDF]

open access: yesNature Reviews Disease Primers, 2020
Most head and neck cancers are derived from the mucosal epithelium in the oral cavity, pharynx and larynx and are known collectively as head and neck squamous cell carcinoma (HNSCC). Oral cavity and larynx cancers are generally associated with tobacco consumption, alcohol abuse or both, whereas pharynx cancers are increasingly attributed to infection ...
Johnson, Daniel E   +5 more
  +10 more sources

Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment

open access: yesFrontiers in Pharmacology, 2023
Head and neck squamous cell carcinoma is a disease that most commonly produce tumours from the lining of the epithelial cells of the lips, larynx, nasopharynx, mouth, or oro-pharynx. It is one of the most deadly forms of cancer.
Bedanta Bhattacharjee   +7 more
doaj   +1 more source

Early postoperative serum albumin levels as predictors of surgical outcomes in head and neck squamous cell carcinoma

open access: yesBrazilian Journal of Otorhinolaryngology, 2022
Background: Malnutrition is a common issue in patients with head and neck squamous cell carcinoma and has a negative effect on surgical outcomes. Objective: We attempted to determine which malnutrition diagnostic variables can be used as predictors of ...
Tercio Guimarães Reis   +6 more
doaj   +1 more source

The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease

open access: yesFrontiers in Oncology, 2023
Among cancer treatments, immunotherapy is considered a promising strategy. Nonetheless, only a small number of individuals with head and neck squamous cell carcinoma exhibit positive responses to immunotherapy.
Yangju Fu, Yongbo Zheng
doaj   +1 more source

Cutaneous Squamous Cell Carcinoma of the Head and Neck [PDF]

open access: yesJournal of Skin Cancer, 2011
Cutaneous squamous cell carcinoma of the head and neck is an epidemic that reaches all parts of the world. Making the diagnosis relies on the acumen of the clinician and pathologist. Various pathologic subtypes exist and differ in histology and prognosis.
Vivek V. Gurudutt, Eric M. Genden
openaire   +3 more sources

Squamous cell carcinoma of the head and neck in the elderly [PDF]

open access: yesReports of Practical Oncology & Radiotherapy, 2013
The incidence of head and neck squamous cell carcinoma (HNSCC) peaks between the fifth and seventh decades of life. With prolongation of life expectancy, however, the proportion of elderly HNSCC patients is also increasing, which makes HNSCC in this life period an important issue for healthcare providers.
Gugić, Jasenka, Strojan, Primož
openaire   +2 more sources

Exosomes in Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesFrontiers in Oncology, 2019
Exosomes are small membranous vesicles that contain proteins, lipids, genetic material, and metabolites with abundant information from parental cells. Exosomes carry and deliver bioactive contents that can reprogram the functions of recipient cells and modulate the tumor microenvironment to induce pathological events through cell-to-cell communication ...
Cheng Xiao   +5 more
openaire   +3 more sources

Immunotherapy for Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesCurrent Oral Health Reports, 2016
Head and neck squamous cell carcinoma has been found to be an immunosuppressive malignancy, with many defects in the host immune system contributing to the progression of disease. A greater understanding of these defects has lead to the identification and investigation of new therapeutic strategies, targeting immune system dysfunction in an effort to ...
Rebecca C, Hoesli, Jeffrey S, Moyer
openaire   +5 more sources

Immunotherapy for Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesHematology/Oncology Clinics of North America, 2015
Although head and neck squamous cell carcinoma has traditionally been considered to be a very immunosuppressive, or at least nonimmunogenic, tumor type, recent results from clinical studies of immune checkpoint blockade strategies have led to resurgence in the enthusiasm for immunotherapeutic approaches. Additional strategies for immunotherapy that are
David W, Schoppy, John B, Sunwoo
openaire   +4 more sources

Home - About - Disclaimer - Privacy